The settlement of the patent infringement suit captioned “Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,” remains subject to review by the U.S. Federal Trade Commission.
In…
Forest Laboratories Inc. and H. Lundbeck A/S face Caraco Pharmaceutical Laboratories, Ltd.’s declaratory judgment action for non-infringement of a third patent for Lexapro.
Lexapro was developed by the Company and Lundbeck,…
The patent infringement suit captioned Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,
remains pending in the U.S. District Court for the Eastern District of Michigan.
In September…
A trial on Caraco Pharmaceutical Laboratories, Ltd.’s action against Forest Laboratories Inc. and H. Lundbeck A/S seeking a declaratory judgment of non-infringement is scheduled to begin on Oct. 27, 2009.
In…
Ortho-McNeil Pharmaceutical Inc. intends to appeal the decision granting Caraco Pharmaceutical Laboratories Ltd.’s motion for summary judgment on Ortho-McNeil’s reissue patent, according to the Company’s latest Form 10-Q filed with…
Discovery is scheduled to continue in Forest Laboratories Inc.’s suit against Caraco Pharmaceutical Laboratories Ltd. for the alleged infringement of U.S. Patent No. Re. 24,712 in the U.S. District Court…
Forest Laboratories Inc.’s patent infringement suit against Caraco Pharmaceutical Laboratories Ltd. over U.S. Patent No. 6,916,941, in the U.S. District Court for the Eastern District of Michigan is in discovery.
On…
Discovery in Novo Nordisk A/S and Novo Nordisk Inc.’s suit against Caraco Pharmaceutical Laboratories Ltd. and Sun Pharmaceutical Industries Ltd. for the alleged infringement of U.S. Patent No. 6,677,358 is…
Caraco Pharmaceutical Laboratories Inc. and Sun Pharmaceutical Industries Ltd., during the quarter period ended Dec. 31, 2008, reached an agreement with Schering Corp., dismissing its suit for alleged infringement of…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).
The ‘221 patent claims combinations of acetaminophen…